Month: March 2023

Demonstrates Strong Revenue Growth Despite Challenging e-Commerce Environment Provides Full Year 2023 Revenue and Net Income Guidance REDMOND, Wash., March 31, 2023 (GLOBE NEWSWIRE) — Hour Loop, Inc. (NASDAQ: HOUR) (“Hour Loop”), a leading online retailer, announces its financial and operational results for the year ended December 31, 2022. Financial Highlights for 2022:Net revenues increased 52.8% to $95.9 million in 2022, compared to $62.8 million in 2021. Net loss totaled $1.5 million, compared to net income of $4.8 million in 2021. Cash used in operating activities in 2022 was $11.6 million, compared to cash provided by operating activities of $7.8 million in 2021.Management Commentary “We are pleased to report our full year 2022 results, in which we delivered great performance in terms of revenue growth,” said Sam Lai,...

Opened a Phase 1/2 clinical study of VISTA Targeting KVA12123 for Advanced Solid Tumors Initial Data Readout Anticipated by End of 2023 Successfully Completed the Reverse Merger with Nasdaq-listed Yumanity Therapeutics SEATTLE , March 31, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today financial results for the full-year ended December 31, 2022 and provided a corporate update. “2022 was transformational for Kineta, culminating with the successful completion of our reverse merger with Nasdaq-listed Yumanity Therapeutics,” said Shawn Iadonato, Ph.D., Chief Executive Officer of Kineta. “We enter this year with tremendous progress advancing KVA12123 into clinical development,...

MONTREAL, March 31, 2023 (GLOBE NEWSWIRE) — Senvest Capital Inc. today reported net loss attributable to common shareholders of ($326.1) million or ($130.98) per share for the year ended December 31, 2022. This compares to net income attributable to common shareholders of $733.0 million or $289.32 per share for the year 2021. Financial statements are available online at Sedar www.sedar.com  CONSOLIDATED STATEMENTS OF INCOME  (in millions of dollars, except per share amounts)  For the years ended       December 31, 2022   December 31, 2021       Net income (loss) attributable to common shareholders $(326.1 ) $733.0     Diluted earnings (loss) per shareattributable to common shareholders $(130.98 ) $289.32Contact: George Malikotsis, Vice President Finance(514) 281-8082www.senvest.com                 ...

EDEN PRAIRIE, Minn., March 31, 2023 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today reported fourth quarter and full year 2022 financial results and provided a corporate update. “Miromatrix is focused on providing patients with acute liver failure access to miroliverELAP™ as soon as possible,” said Jeff Ross, Ph.D., Miromatrix CEO. “We are pioneering a new class of therapies with our bioengineered organs and believe that achieving FDA clearance to initiate a Phase 1 clinical trial for miroliverELAP will provide important validation.   To achieve this significant milestone as rapidly as possible we will be concentrating the majority of our resources...

ObsEva Files Year End 2022 Financial Statements Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 31, 2023 – ObsEva SA (SIX: OBSN / OTC Pink Market: OBSVF), a biopharmaceutical company developing and commercializing novel therapies to improve women’s health, today published its U.S. Annual Report on Form 10-K for Fiscal Year 2022, including the U.S. GAAP financial results for year-end 2022. The U.S. Annual Report on Form 10-K can be accessed in the financial section of the Company’s website, here or directly via the link here. ObsEva expects to publish its Swiss Annual Report to Shareholders, including the financial results for year end 2022 in IFRS, in the week commencing April 24, 2023. About ObsEvaObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive...

BOSTON, March 31, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer using RNA therapeutics, today reported financial results for 2022 and recent business progress. “Despite the continued turbulence in the biotech sector, 2022 was extremely productive and, we believe, successful for TransCode. The year was highlighted by FDA’s approval to proceed with our planned Phase 0, First-In-Human, clinical trial with our lead therapeutic candidate in cancer patients with advanced solid tumors,” said Michael Dudley, Co-Founder, President and CEO of TransCode. “We achieved many important milestones, advancing our pipeline of therapeutic candidates enabled by our proprietary delivery platform. We also continued to de-risk our therapeutic candidates as we march toward the...

KING OF PRUSSIA, Pa., March 31, 2023 (GLOBE NEWSWIRE) — Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks today announced results for its fourth quarter and twelve months ended December 31, 2022. Nocopi’s SEC filings are available here. 2022 Q4 Results 2022 Q4 revenue was $3,087,600, a substantial increase over 2022 Q4 revenue of $514,100 that largely reflects increased licensee revenue from the renewal of the company’s largest licensee for a new five-year extension term. Additionally, the company entered into a new license agreement with a new domestic and international licensee in the children’s entertainment space. Excluding licenses and royalty revenue, revenue in the fourth quarter compared to 2021 Q4 for product and other sales were negatively impacted from a modest decline in specialty ink...

PHOENIX, March 31, 2023 (GLOBE NEWSWIRE) — QuoteMedia, Inc. (OTCQB: QMCI), a leading provider of market data and financial applications, announced financial results for the fiscal year ended December 31, 2022. QuoteMedia provides banks, brokerage firms, private equity firms, financial planners and sophisticated investors with a more economical, higher quality alternative source of stock market data and related research information. We compete with several larger legacy organizations and a modest community of other smaller companies. QuoteMedia provides comprehensive market data services, including streaming data feeds, on-demand request-based data (XML/JSON), web content solutions (financial content for website integration) and applications such as Quotestream Professional desktop and mobile. Highlights for fiscal 2022 include...